Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity-Reference-Cited by-同舟云学术

Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity

Published:2001-04 Issue:1 Volume:113 Page:81-86
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Ljung Rolf,Petrini Pia,Tengborn Lilian,Sjörin Elsy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02759.x/fullpdf

Reference36 articles.

1. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations;Attali;Thrombosis and Haemostasis,1999

2. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies;Becker;American Journal of Human Genetics,1996

3. A new MspI restriction fragment length polymorphism in the hemophilia B locus;Camerino;Human Genetics,1985

4. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series;Chen;Human Genetics,1991

5. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions;Cooper;Human Genetics,1990

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B;Thrombosis and Haemostasis;2023-07-26

2. The Clinical Genetics of Hemophilia B (Factor IX Deficiency);The Application of Clinical Genetics;2021-11

3. Safety, pharmacokinetics, and pharmacodynamics of a next‐generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients;Journal of Thrombosis and Haemostasis;2021-03-24

4. The novel mutation p.Asp315Tyr causes severe hemophilia B by impairing coagulation factor IX expression;Thrombosis Research;2021-02

5. Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients;Research and Practice in Thrombosis and Haemostasis;2020-07-29